WeVote
Log In

Bill

Bill

SR 101

MEMORIAL-RONALD GAYLE BITTLE

104th Regular Session Introduced by Dale Fowler

SR 101 requests an assessment of the social and financial impacts of mandatory health insurance coverage for continuous glucose monitors, affecting patients and insurers.

Resolution Adopted
0
WeVote Research Nonpartisan
Bill Summary · SR 101

Summary of SR 101: Requesting an Assessment on Mandatory Health Insurance Coverage for Continuous Glucose Monitors

Bill Overview

Bill Number: SR 101
Title: Requesting the Auditor to Assess the Social and Financial Effects of Proposed Mandatory Health Insurance Coverage for Continuous Glucose Monitors
Status: Deferred by the committee on Health and Human Services (HHS)
Introduced Date: March 07, 2025
Classification: Resolution
Subject Areas: Auditor, Continuous Glucose Monitors, Impact Assessment Report, Mandatory Health Insurance Coverage

Purpose and Intent

The primary intent of SR 101 is to request a comprehensive assessment by the state auditor regarding the social and financial implications of implementing mandatory health insurance coverage for continuous glucose monitors (CGMs). This resolution aims to evaluate how such coverage could affect patients, healthcare providers, and the overall healthcare system.

Key Provisions

  • Assessment Request: The resolution calls for the state auditor to conduct a thorough analysis of the potential impacts of mandating health insurance coverage for CGMs.
  • Focus Areas: The assessment will specifically look at:
    • Financial Effects: Costs associated with coverage for CGMs, including potential impacts on insurance premiums and overall healthcare spending.
    • Social Effects: How mandatory coverage could affect patient outcomes, access to care, and quality of life for individuals with diabetes who rely on CGMs for monitoring their blood glucose levels.

Affected Parties

  • Patients: Individuals with diabetes who may benefit from CGMs as a means of better managing their condition.
  • Healthcare Providers: Doctors and healthcare facilities that prescribe or provide CGMs and may see changes in patient care protocols.
  • Insurance Companies: Insurers that would be required to cover CGMs, potentially affecting their pricing structures and policies.
  • State Government: The auditor's office will be tasked with conducting the assessment, which may require additional resources and funding.

Legislative Timeline

  • March 07, 2025: SR 101 was introduced and offered for consideration.
  • March 12, 2025: The bill was referred to the committees on Health and Human Services (HHS) and Ways and Means (WAM).
  • March 20, 2025: A public hearing was scheduled for March 24, 2025, at 1:05 PM in Conference Room 225 and via videoconference.
  • March 24, 2025: The measure was deferred by the HHS committee, indicating that further discussion or action on the bill will be postponed.

Related Legislation

  • HR 167: A related bill that may address similar issues regarding health insurance coverage for CGMs.
  • SCR 120: A companion resolution that could provide additional context or support for the objectives of SR 101.

Conclusion

SR 101 seeks to ensure that any decision regarding mandatory health insurance coverage for continuous glucose monitors is informed by a detailed assessment of its potential social and financial impacts. The resolution's deferral by the HHS committee suggests that further deliberation is needed before moving forward with any legislative action.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.